ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
AstraZeneca
A Development Scientist III in Viral Vector Analytical Development at Alexion contributes to the advancement of the genomic medicine portfolio by supporting analytical capabilities for recombinant AAV viral vectors. The role sits within the Genomic Medicine organization at Alexion and is positioned in a lab-focused R&D environment that interfaces with development and regulatory functions. It involves working on innovative therapies within a collaborative, science-driven company culture.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Senior Scientist, Analytical Development
Zymeworks
Scientist I, Analytical Development (Protein-Based Assays)
Forge Biologics
Scientist, Viral Vector Analytical Development
Eurofins
Scientist/Senior Scientist, Viral Vector Analytical Development
Obsidian Therapeutics
Associate Scientist II, Analytical Development (Protein-Based Assays)
Forge Biologics
Advisor, Downstream Process Development – Viral Vectors
Eli Lilly and Company